StonvexLoading…
StonvexStonvexStonvexCore line items from APLE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.41B | $1.43B | $1.34B | $1.24B |
Operating Income | $257.80M | $292.76M | $247.48M | $206.48M |
Net Income | $175.36M | $214.06M | $177.49M | $144.81M |
EPS (Diluted) | $0.74 | $0.89 | $0.77 | $0.63 |
Total Assets | $4.90B | $4.97B | $4.94B | $4.77B |
Total Liabilities | $1.75B | $1.70B | $1.61B | $1.59B |
Cash & Equivalents | $8.52M | $10.25M | $10.29M | $4.08M |
Free Cash Flow OCF − CapEx | $282.81M | $325.01M | $326.98M | $309.07M |
Shares Outstanding | 235.64M | 239.77M | 241.52M | 228.64M |